Monobactams

DBCAT000782Pharmacologic classJ01DF

Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized. A DrugBank category of 3 drugs. 1 of them is approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J01 — ANTIBACTERIALS FOR SYSTEMIC USE
J01D — OTHER BETA-LACTAM ANTIBACTERIALS
J01DF — Monobactams
Also known as: Antibiotics, Monobactam · beta Lactams, Monocyclic · beta-Lactams, Monocyclic · Monobactam Antibiotics · Monocyclic beta Lactams
Drugs: Aztreonam
Carumonam
Oximonam

What you can answer from here — as of October 27, 2022

3DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

38Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Monobactams share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account